CST5 and glioblastoma: Among the various factors examined, Cystatin D exhibited a positive correlation with the risk of glioblastoma (Odds ratio [OR], 1.27; 95% confidence interval [CI]: 1.06–1.52; p = 0.01) when utilizing inverse variance weighted (IVW) methods (Figure 2).